VOR BIOPHARMA Trademark

Trademark Overview

On Friday, August 9, 2019, a trademark application was filed for VOR BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the VOR BIOPHARMA trademark a serial number of 88572618. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2023. This trademark is owned by VOR BIOPHARMA, INC.. The VOR BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

cell therapy preparations, namely, stem cells and progenitor cells for medical purposes; pharmaceutical preparations for the treatment of hematological and oncologic disorders; cells for medical or clinical use; cells for medical or clinical use, namely, cells featuring chimeric antigen receptors
vor biopharma

General Information

Serial Number88572618
Word MarkVOR BIOPHARMA
Filing DateFriday, August 9, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements

Goods and Servicescell therapy preparations, namely, stem cells and progenitor cells for medical purposes; pharmaceutical preparations for the treatment of hematological and oncologic disorders; cells for medical or clinical use; cells for medical or clinical use, namely, cells featuring chimeric antigen receptors
Pseudo MarkVOR BIO PHARMACY
Translation of Words in MarkThe English translation of the word "Vor" in the mark is "before".
NOT AVAILABLE"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 26, 2019
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameVOR BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, US 02116
Party NameVOR BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, US 02116

Trademark Events

Event DateEvent Description
Tuesday, August 13, 2019NEW APPLICATION ENTERED
Monday, August 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2019ASSIGNED TO EXAMINER
Thursday, November 14, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, November 14, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, November 14, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, November 14, 2019ASSIGNED TO LIE
Friday, November 15, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Wednesday, May 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 18, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 18, 2021SOU EXTENSION 1 FILED
Thursday, February 18, 2021SOU EXTENSION 1 GRANTED
Saturday, February 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 5, 2021SOU TEAS EXTENSION RECEIVED
Thursday, August 5, 2021SOU EXTENSION 2 FILED
Thursday, August 5, 2021SOU EXTENSION 2 GRANTED
Saturday, August 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 4, 2022SOU EXTENSION 3 FILED
Friday, February 4, 2022SOU EXTENSION 3 GRANTED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 30, 2022SOU EXTENSION 4 FILED
Thursday, June 30, 2022SOU EXTENSION 4 GRANTED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 10, 2023SOU EXTENSION 5 FILED
Monday, February 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 28, 2023SOU EXTENSION 5 GRANTED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, September 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

biopharma cells medical clinical namely preparations featuring disorders oncologic antigen receptors